ClinConnect ClinConnect Logo
Search / Trial NCT03469440

Goal Directed Therapy Aiming to Optimise Oxygen Central Venous Saturation in Children Undergoing Cardiac Surgery

Launched by INSTITUTO DO CORACAO · Mar 15, 2018

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Lactate Central Venous Saturation Pediatric Cardiac Surgery

ClinConnect Summary

This clinical trial is studying a treatment approach called goal-directed therapy for children who are having heart surgery. The aim is to see if using continuous monitoring of a specific measure called central venous saturation can improve care compared to the usual treatment. This study is focused on children who are scheduled for elective heart surgeries that require a heart-lung machine, which helps to pump blood and oxygen during the procedure.

To be eligible for this trial, children must be undergoing planned heart surgery and have parental consent. However, those with certain conditions like heart rhythm problems, emergency surgeries, or serious heart issues may not qualify. Participants will receive either the new therapy or standard care during their surgery, and the study will help researchers understand which approach leads to better outcomes. If you are considering this trial for your child, it’s important to discuss it with your healthcare team to understand all the details and what it involves.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Elective cardiac surgery with cardiopulmonary bypass
  • Written informed consent
  • Exclusion Criteria:
  • Cardiac arrhythmia
  • Emergency operation
  • Hemodynamic instabillty (norepinephrine higher than 1 mcg/kg/min)
  • Neoplasia
  • Heart transplant
  • Participation in another study

About Instituto Do Coracao

Instituto do Coração (InCor) is a leading clinical research institution dedicated to advancing cardiovascular health through innovative research and patient-centered care. As a prominent affiliate of the University of São Paulo, InCor focuses on the prevention, diagnosis, and treatment of heart diseases, harnessing cutting-edge technologies and methodologies to conduct clinical trials. The institute is committed to enhancing medical knowledge and improving patient outcomes by collaborating with healthcare professionals, researchers, and industry partners. With a strong emphasis on ethical practices and scientific rigor, InCor aims to contribute to the global understanding of cardiovascular conditions and foster the development of new therapeutic strategies.

Locations

Sao Paulo, , Brazil

Patients applied

0 patients applied

Trial Officials

Flavio M Ferreira, Phd

Principal Investigator

HCFUSP

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials